Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

SLC39A6: A potential target for diagnosis and therapy of esophageal carcinoma

Cui, XB and Shen, YY and Jin, TT and Li, S and Li, TT and Zhang, SM and Peng, H and Liu, CX and Li, SG and Yang, L and Li, N and Hu, JM and Jiang, JF and Li, M and Liang, WH and Li, Y and Wei, YT and Sun, ZZ and Wu, CY and Chen, YZ and Li, F (2015) SLC39A6: A potential target for diagnosis and therapy of esophageal carcinoma. Journal of Translational Medicine, 13 (1).

[img]
Preview
PDF
Published Version
Available under License : See the attached license file.

Download (13MB) | Preview
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)

Abstract

© 2015 Cui et al. Background: Esophageal squamous cell carcinoma (ESCC) is a highly lethal cancer, and its underlying molecular mechanisms are poorly understood. Recent large-scale genome-wide association studies in Chinese Han populations have identified an ESCC susceptibility locus within the SLC39A6 gene. Here, we sought to explore the expression and biological function of SLC39A6 in ESCC. Methods: Multiethnic validation of SLC39A6 protein expression was performed in different cohorts of patients from Chinese Han and Kazakh populations in the Xinjiang region by immunohistochemistry. The associations among SLC39A6 expression, clinicopathological parameters, and prognosis outcomes of ESCC were analyzed. And the effects of SLC39A6 silencing by siRNA on cell proliferation, apoptosis, and invasiveness, as well as the proteins involved in epithelial-to-mesenchymal transition (EMT) of esophageal cancer cells, were studied. Results: SLC39A6 protein expression increased progressively from normal esophageal epithelium (NEE) to low-grade intraepithelial neoplasia to ESCC, and finally reached the highest in high-grade intraepithelial neoplasia from Han ethnic. Similarly, SLC39A6 protein was significantly overexpressed in Kazakh ethnic ESCC compared with that in NEE. Increased expression of SLC39A6 was found to be closely correlated with histological grade and early Tumor-Node-Metastasis stage I/II. High tumorous SLC39A6 expression was significantly correlated with shorter overall survival (OS). Cox regression analysis confirmed that SLC39A6 expression was an independent prognostic factor for poor OS in ESCC. Experimentally, the suppression of SLC39A6 expression promoted ESCC cell apoptosis but abrogated proliferation and invasion, and induced an EMT phenotype that included enhanced expression of E-cadherin, loss of vimentin, and morphological changes in ESCC cells in vitro. Conclusions: Combined, our findings highlight a tumor-promoting role for SLC39A6 in ESCC, suggesting that SLC39A6 could serve as an early detector of high-risk subjects and prognostic biomarker. The targeting of SLC39A6 might be a potential therapeutic strategy for blocking ESCC.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: Article
Status: Published
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Cui, XB
Shen, YY
Jin, TT
Li, S
Li, TT
Zhang, SM
Peng, H
Liu, CX
Li, SG
Yang, L
Li, N
Hu, JM
Jiang, JF
Li, M
Liang, WH
Li, Y
Wei, YT
Sun, ZZ
Wu, CYcarywu@pitt.eduCARYWU
Chen, YZ
Li, F
Date: 6 October 2015
Date Type: Publication
Journal or Publication Title: Journal of Translational Medicine
Volume: 13
Number: 1
DOI or Unique Handle: 10.1186/s12967-015-0681-z
Schools and Programs: School of Medicine > Pathology
Refereed: Yes
Date Deposited: 03 Aug 2016 18:00
Last Modified: 02 Feb 2019 16:58
URI: http://d-scholarship.pitt.edu/id/eprint/29060

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com


Actions (login required)

View Item View Item